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14
15 Introduction
16 The recently published EuroSCORE II [1] refreshed our
17 knowledge of adult cardiac surgical risk and gave us an
18 updated tool for everyday practice. The primary aim of risk
19stratification is to provide information about the likely out-
20come for both the patient and the clinicians. The improve-
21ment of cardiac surgical care is also based on continuous
22quality control, in which the expected and the observed
23outcomes are compared.
Background The efficacy of the updated cardiac surgical risk stratification system, EuroSCORE II, needs widespread
assessment in the cardiac surgical centres where it is intended to be used. The present paper is a single-
centre validation study carried out in Hungary.
Methods An adult cardiac surgical cohort of 2287 patients was investigated. The general levels of performance of the
logistic EuroSCORE and that of EuroSCORE II were compared using the Hosmer-Lemeshow test, ROC
analysis and calculation of the Brier score. The calibrations were visualised by smoothed curves derived
with the help of local polynomial regression. The efficacy of EuroSCORE II was analysed in different
operation types and urgency subgroups.
Results The old EuroSCORE over-estimated the risk (O:E ratio: 0.66, HL test, p<0.01), while EuroSCORE II slightly
under-predicted mortality (O:E ratio:1.19, HL test, p=0.0084). Comparing the ROC AUCs, we did not find a
significant difference between the accuracy of the old and new versions of EuroSCORE (0.8017, 95%
CI:0.7596-0.8438 vs. 0.8177 95% CI: 0.7786-0.8569). EuroSCORE II performed well among CABG patients
(O:E ratio: 0.75, HL test, p=0.5789) and in those who underwent elective surgery (O:E ratio: 1.1, HL test,
p=0.1396), but failed in the emergency (O:E ratio: 1.71, HL test, p=0.0055) and salvage (O:E ratio:1.36, HL
test, p=0.0245) categories.
Conclusions EuroSCORE II proved to be more suitable for cardiac surgical risk prediction compared with its previous
version, but its reliability can be questioned among patients who need emergency and salvage surgery, as
well as in the case of combined operations.
Keywords Risk model  Cardiac surgery  EuroSCORE  Mortality  Risk stratification  Validation
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A valid risk stratification system will be of paramount
24 importance in clinical decision making when choosing
25 between cardiac operations and catheter-based interventions,
26 which are now available offering a palliative, but lower-risk
27 solution for an increasing number of cardiac conditions. To
28 confirm the practical usefulness of the new EuroSCORE sev-
29 eral external validation studies are needed in different
30 countries.
31 Our institution participated in the data collection process
32 for the recalibration of EuroSCORE, but neither its present
33 nor its old version [2] has been validated in Hungary to date.
34 The aim of the present study is to examine the calibration and
35 accuracy of EuroSCORE II on a Hungarian adult cardiac
36 surgical population.
We suspected that the performance of EuroSCORE in
37 Hungary might be different from that of other regions in
38 Europe. There are several reasons behind this assumption:
39 (1) different genetic background of the population, (2)
40 socio-cultural aspects, (3) different economic resources of
41 the health care system. These factors are not or poorly
42 represented in the EuroSCORE II. risk model, because
43 the majority of the patients enrolled into the developmental
44 database came from the Western European region, that
45 basically differs from the Eastern and Middle Europe as
46 well as from Asia and Australia in the above-mentioned
47 aspects.
48 There are certain published data that indirectly suggest
49 strong a genetic influence behind the risk factors of cardiac
50 disease in the Hungarian population. Farsang et al [3]
51 reported increased incidence of cardio-metabolic syndrome
52 in the Central European population compared with other
53 regions of Europe. Beyond the inherited factors the explan-
54 ations for the unfavourable risk profile in Central-Europe can
55 be life-style (low level of physical exercise and high amount
56 of saturated fat in the diet).
57 On the bases of theWHOon-line database (http://www.who.
58 int/countries/en/) one can explore the differences among the
59 countries which contributed data to the new EuroSCORE.
60 The expenditure on health per capita is around 50% com-
61 pared with the Western European countries but the hazard-
62 ous effect the more frequent smoking places on health care
63 is disproportionally higher. The probability of dying
64 between the 15th and the 60th years of life is more than
65 the double (208/1000) for males in Hungary compared with
66 the Western European data (United Kingdom: 91/1000;
67 Austria: 94/1000; Germany: 96/1000; France: 113/1000).
68 These indices in other Central European countries are
69 the following: the Czech Republic: 132/1000; Slovakia:
70 170/1000; Poland: 191/1000; Romania: 209/1000; the
71 Ukraine: 310/1000. For comparison the same ratio is
72 80/1000 in Australia.
73 The present publication aims at exploring the performance
74 of EuroSCORE II independently of these three non-specified
75 determinants.
76 In addition to describing EuroSCORE II’s general perfor-
77 mance, we also aimed to explore its efficacy in the different
78 cardiac surgical groups, as well as in the urgency categories.
79Patients and Methods
80The recruitment of the validation cohort started on 1st
81November 2010 and ended on 31st January 2013 in a single
82cardiac surgical centre, shortly after the data collection for
83EuroSCORE II ended. All the patients who underwent major
84cardiac surgical procedures (CABG, AVR,MVR, mitral valve
85repair, ascending aorta replacement or repair, atrial septal
86defect closure, atrial myxoma excision, or a combination of
87these) were enrolled and followed up to the 30th postopera-
88tive day. The same risk predictors were collected as had been
89provided for the developmental EuroSCORE II database, but
90none of the patients was included in both datasets. All the
91patients enrolled into this validation study signed an
92informed consent form in which they agreed with the use
93of the data collected for their disease, their treatment and
94outcomes for scientific and publication purposes. The study
95was approved by the local ethical committee. The only out-
96come parameter was in hospital mortality within this period.
97For the calculation of the logistic EuroSCORE and the
98EuroSCORE II p-values, the online tools were used that
99can be found on the website: www.euroscore.org.
100The distribution of the calculated risks was depicted on a
101Logistic EuroSCORE-EuroSCORE II-scatter plot with differ-
102ent symbols for the survivors and non-survivors.
103The basic overall performance parameter was the observed
104to expected mortality ratio (O:E ratio). The practical meaning
105of the individual logistic EuroSCORE and EuroSCORE II
106p-value is the probability of death within 30 days following
107the operation. The expected mortality was calculated by
108averaging out these probabilities [4].
109Calibrations of the scores were evaluated using the
110Hosmer-Lemeshow test. The expected mortalities in the dec-
111iles of the predicted risk were calculated on the basis of both
112models, similar to above, by averaging the individual
113p-values and comparing them with the observed mortality
114in each decile. The difference between the observed and the
115expected mortality was considered to be statistically signifi-
116cant if the HL-test result was <0.05 [4]. In order to demon-
117strate the goodness-of-fit visually, calibration curves were
118created by using a smoothing method. These curves are the
119results of a local polynomial regression where Epanechnikov
120kernel function was used with a bandwidth of 0.05 [5].
The accuracy or discriminative power of the risk stratifica-
121tion models were analysed by using the receiver operation
122characteristics (ROC)method. The area under the ROC curves
123and their 95% confidence intervals were calculated and
124compared [4].
125As another general measure of accuracy the Brier score of
126each individual outcome prediction was calculated accord-
127ing to the following formulas:
Brier score (BS) = (p-1)2 if the patient died and (p-0)2 if the
128patient survived,where p is the probability ofmortalitywithin
12930 days following the surgery, predicted by either the logistic
130EuroSCORE or EuroSCORE II [4]. The reported BS values are
131the means of these individual Brier scores. If we know the
132outcome, the Brier score is zero when the prediction is perfect
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133 and – analogous to tossing a coin – it is 0.25 or higherwhen the
134 prediction isuninformativeorevenmisleading.The frequency
135 of patients with individual BS 0.25 is also reported.
136 Cardiac surgical subgroups were created according to the
137 weight of intervention option (isolated coronary, single non-
138 coronary, two procedures, three procedures) and on the basis
139 of the procedural urgency (elective, urgent, emergent, sal-
140 vage) and the same calibration and accuracy parameters
141 were calculated, but only in connection with EuroSCORE II.
142 If the size of a certain group was too small, the HL-test was
143 modified: the individual risks were sorted into five of three
144 groups rather than into deciles, in order to gain appropriate
145 statistical power in each subgroup. The results of the modi-
146 fied HL-tests were indicated with *, if five and **, if three
147 groups were used.
148 The continuous numerical data were reported as means
149 along with their standard deviation, while the categorical
150 data were reported as frequencies and their relevant percen-
151 tages throughout the text. The results of the statistical tests
152 were considered to be significant if p<0.05.
153 The collection and processing of the data were performed
154 with the help of the STATA 10 statistical package (STATA
155 Corp., Texas, USA).
156 Results
157 General Description of the Cohort,
158 Frequency of Risk Predictors and
159 Distribution of the Risk
160 The frequency of the risk predictors are summarised in Table
161 1. A total of 2287 patients were included in the analysis, 1491
162 males and 796 females. Females were significantly older than
163 males (61.710.1 years vs. 64.49.8 years, p<0.01) and had a
164 higher risk according to both scores. Logistic EuroSCORE
165 probabilities were 0.07270.1037 for males vs. 0.09820.1380
166 for females, p<0.001. EuroSCORE II probabilities were 0.0397
0.0619 for males vs. 0.05530.0901 for females, p<0.001.
168 Table 2 lists the cardiac surgical procedures and their
169 frequencies in the validation cohort. Single coronary oper-
170 ations were performed in 1038 cases (45.4%), the majority of
171 which were on-pump procedures. Aortic valve replacement
172 (AVR) was the most frequent non-coronary intervention.
173 The expected mortality of 8.18% (95% CI: 7.7-8.6%) as
174 calculated by the logistic EuroSCORE, was significantly
175 higher than the 4.5% (95%CI: 4.2% -4.8%)mortality predicted
176 by EuroSCORE II, p<0.01. 123 persons (5.4%) died within
177 30 days following cardiac surgery.
178 The scatter plot in Fig. 1 depicts a comparison of the new
179 and old scores. The logistic EuroSCORE indicated higher
180 risks in the majority of the cases. The EuroSCORE II p-values
181 were higher in only 244 Individuals, of whom 109 died.
182 Calibration of the Logistic EuroSCORE
183 and EuroSCORE II
184 Table 3 summarises the results of the Hosmer-Lemeshow test
185 of the old logistic EuroSCORE. The logistic EuroSCORE
Table 1 Basic characteristics of the cohort.
RISK PREDICTOR
age
years (SD) 62.7 (10.1)
gender
male, n (%) 1491 (65.2)
female, n (%) 796 (34.8)
creatinine clearence
>85, n (%) 1143 (50)
85-50, n (%) 862 (37.7)
<50, n (%) 254 (11.1)
on HD, n (%) 28 (1.2)
extracardiac arteriopathy
n (%) 769 (33.6)
poor mobility
n (%) 64 (2.8)
previous cardiac surgery
n (%) 121 (5.3)
chronic lung disease
n (%) 373 (16.5)
active endocarditis
n (%) 74 (3.2)
critical preoperative state
n (%) 81 (3.5)
diabetes on insulin
n (%) 304 (13.3)
NYHA grade
I, n (%) 210 (9.2)
II, n (%) 911 (39.8)
III, n (%) 1079 (47.2)
IV, n (%) 87 (3.8)
angina at rest
n (%) 264 (11.5)
ejection fraction
>50%, n (%) 1300 (56.8)
31-50%, n (%) 879 (38.4)
21-30%, n(% 100 (4.4)
<20%, n (%) 8 (0.4)
MI within 90 days
n (%) 301 (13.2)
pulmonary hypertension
<30 mmHg, n, (%) 1423 (62.2)
31-55 mmHg, n (%) 670 (29.3)
>55 mmHg, n (%) 194 (8.5)
urgency
elective, n (%) 1694 (74.1)
urgent, n (%) 488 (21.3)
emergent, n (%) 77 (3.4)
salvage, n (%) 28 (1.2)
surgery on the thoracic aorta
n (%) 115 (5)
postinfarct septum rupture
n (%) 18 (0.8)
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186 predicted a significantly higher (p<0.01) mortality than we
187 observed. This discrepancy continued to exist even in the
188 highest risk deciles. The only exceptionwas the second decile.
189 The overall O:E ratio was 0.66. The smoothed curve in Fig. 2
190runs below the theoretical ‘‘perfect-match’’ reference line in all
191risk categories except for the very highmortality probabilities.
192The Hosmer-Lemeshow test (Table 4) also revealed a sig-
193nificant deviation between expected and observed mortality
194(p=0.0084) when EuroSCORE II was used for the outcome
195prediction, but in this case the observed was slightly higher
196than the expected mortality (O:E ratio = 1.19). The smoothed
197curve in Fig. 3 gives a visual impression of the calibration of
198EuroSCORE II. It demonstrates that the difference between
199the observed and the predicted outcome is greatest among
200the highest risk individuals, where EuroSCORE II spectacu-
201larly underestimated the operative risk.
Table 2 Types and frequencies of cardiac surgical
procedures.
SURGICAL SUBGROUP n (%)
ISOLATED CORONARY OPERATIONS 1038 (45.4)
on-pump 1002 (43.8)
off-pump 36 (1.6)
OTHER THAN ISOLATED CORONARY
OPERATIONS
1249 (54.6)
single non-coronary 491 (21.5)
AVR 258 (11.3)
MVR 60 (2.6)
mitral valve repair 70 (3.1)
ascending aorta replacement or repair 32 (1.4)
ASD closure 46 (2.0)
cardiac myxoma 25 (1.1)
two procedures 576 (25.2)
AVR+CABG 214 (9.6)
AVR+mitral valve repair 27 (1.2)
MVR+ tricuspid valve repair 35 (1.5)
MVR+CABG 83 (3.8)
CABG+mitral valve repair 97 (4.2)
mitral+tricuspid valve repair 47 (2.1)
AVR+MVR 23 (1.0)
AVR+ascending aorta replacement or repair 31 (1.4)
CABG+ascending aorta replacement or repair 19 (0.8)
three procedures 182 (8.0)
AVR+CABG+mitral valve repair 97 (4.2)
AVR+ CABG+tricuspid valve repair 27 (1.2)
AVR+CABG+ascending aorta 33 (1.4)
AVR+MVR+CABG 25 (1.1)
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Figure 1 Comparison of the expected mortality pre-
dicted by the logistic EuroSCORE (horizontal axis)
and EuroSCORE II (vertical axis).
Table 3 Logistic EuroSCORE, Hosmer-Lemeshow test results.
Deciles n Observed
mortality, n(%)
Expected
mortality, n(%)
Probability
interval
HL, chi2
1 249 2 (0.8) 3.1 (1.2) 0.009-0.015 0.37
2 242 6 (2.5) 4.2 (1.8) 0.015-0.021 0.74
3 214 0 (0.0) 5.0 (2.3) 0.021-0.025 5,14
4 211 2 (0.9) 6.3 (3.0) 0.026-0.033 3,01
5 229 6 (2.6) 8.7 (3.8) 0.033-0.043 0.87
6 233 6 (2.6) 11.3 (4.9) 0.043-0.055 2.62
7 223 12 (5.4) 14.2 (6.4) 0.055-0.072 0.35
8 229 18 (7.9) 19.9 (8.7) 0.073-0.103 0.20
9 229 14 (6.1) 30.8 (13.4) 0.103-0.175 10.54
10 228 57 (25.0) 83.2 (36.5) 0.175-0.908 12.96
Total 2287 123 (5.4) 186.6 (8.2) 0.009-0.908 36.81
p=0.0001
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202 Accuracy of the Logistic EuroSCORE
203 and EuroSCORE II
204 The sensitivity and specificity of each potential cut-off point
205 were calculated in ROC analysis for both scores (Fig. 4). The
206 results showed an AUC of 0.8177 (95% CI: 0.7786-0.8569) for
207 EuroSCORE II, which is slightly higher than the AUC (0.8017,
208 95% CI: 0.7596-0.8438) of the logistic EuroSCORE, the differ-
209 ence is not significant (p=0.1930).
210The Brier score for EuroSCORE II was 0.0447, which is also
211non-significantly lower than the logistic EuroSCORE’s Brier
212score of 0.0457 (p=0.775).
213The Brier score was equal or higher than 0.25 in the case of
214119 patients (5.2%) if EuroSCORE II was used for the out-
215come prediction. It was 126 (5.5%) with the logistic Euro-
216SCORE. This means that the frequency of inaccurate
217predictions given by the old logistic EuroSCORE was only
0
.5
1
1.5
O
bs
er
ve
d 
pr
op
or
tio
n
0 .2 .4 .6 .8
Predicted proportion
95% CI
smoothed curve
Figure 3 Calibration plot of EuroSCORE II. The
smoothed curve is the result of local polynomial regres-
sion using Epanechnikov kernel function with a band-
width of 0.05.
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Figure 2 Calibration plot of the logistic EuroSCORE.
The smoothed curve is the result of local polynomial
regression using Epanechnikov kernel function with a
bandwidth of 0.05.
Table 4 EuroSCORE II, results of the Hosmer-Lemeshow test.
Deciles n Observed
mortality, n(%)
Expected
mortality, n(%)
Probability
interval
HL, chi2
1 234 0 (0.0) 1.6 (0.7) 0.005-0.008 1.61
2 224 4 (1.8) 2.1 (0.9) 0.008-0.011 1.67
3 231 2 (0.9) 2.8 (1.2) 0.011-0.014 0.25
4 228 6 (2.6) 3.6 (1.6) 0.014-0.017 1.68
5 227 2 (0.9) 4.6 (2.0) 0.018-0.023 1.46
6 230 2 (0.9) 5.9 (2.6) 0.023-0.028 2.63
7 232 10 (4.3) 7.5 (3.2) 0.028-0.037 0.87
8 225 20 (8.9) 9.9 (4.4) 0.037-0.054 10.70
9 228 18 (7.9) 16.3 (7.1) 0.054-0.092 0.20
10 228 59 (25.9) 48.9 (21.5) 0.093-0.718 2.63
Total 2287 123 (5.4) 103.2 (4.5) 0.005-0.718 23.70
p=0.0084
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218 non-significantly higher than that experienced with the new
219 EuroSCORE (p=0.6521).
220 Analysis of Cardiac Surgical Subgroups
221 Further analyses were made on the surgical subgroups cre-
222 ated according to the ‘‘weight of intervention’’ categories
223 defined by EuroSCORE II (Table 5). The result of the
224 Hosmer-Lemeshow test revealed a good calibration for Euro-
225 SCORE II in the single coronary operation group (p=0.5789).
226 The new EuroSCORE slightly over-predicted the risk (O:E
227 ratio=0.75). Its accuracy was also excellent with an AUC of
228 0.8118 (95% CI: 0.7132-0.9105).
229 The calibration in the ‘‘other than isolated coronary’’ group
230 showed less perfect goodness-of-fit with an HL-test p-value
231 of 0.0084. The ROC AUC was also smaller: 0.7873 (95% CI:
232 0.7401 – 0.8345). This group unites extremely diverse inter-
233 ventions and patients (see Table 2) that can be divided into
234 three further subgroups according to the complexity of the
235 intervention.
In the ‘‘single non-coronary’’ group the HL-test indicated
236 poor calibration. Observed mortality was 1.77 times higher
237 than expected mortality. In the two combined operation
238 groups the accuracy of EuroSCORE II diminished with
239 the increasing complexity of the procedure and the
Table 5 Results of the subgroup analyses.
Surgical subgroup N Risk
interval, %
Exp,n
(%)
Obs,
n (%)
O:E HL,
chi2
HL, p ROC
AUC
95%
CI
BS,
mean
BS 0.25,
n (%)
ISOLATED CORONARY 1038 0.5-46.9 29.4 (2.8) 22 (2.1) 0.75 8.52 0.5789 0.8118 0.7132-0.9105 0.0195 22 (2.1)
OTHER THAN
ISOLATED CORONARY
1249 0.5-71.8 73.7 (5.9) 101 (8.1) 1.37 23.70 <0.001 0.7873 0.7401-0.8345 0.0649 97 (7.8)
single non-coronary 491 0.5-65.5 17 (3.5) 30 (6.1) 1.77 31.060 *0.0006 0.8750 0.7904-0.9595 0.0433 28 (5.7)
two procedures 576 0.9-71.8 38.2 (6.6) 45 (7.8) 1.18 34.80 *0.0001 0.7199 0.6358-0.8040 0.0649 45 (7.8)
three procedures 182 2.2-53.0 18.6 (10.2) 26 (14.3) 1,4 34.80 *0.0001 0.6144 0.4926-0.7362 0.1225 24 (13.2)
ELECTIVE PROCEDURES 1649 0.5-41.7 49.3 (2.9) 54 (3.2) 1.1 13.54 0.1396 0.7679 0.6998-0.8360 0.0291 54 (3.3)
NON-ELECTIVE
PROCEDURES
593 0.8-71.8 53.9 (9.1) 69 (11.6) 1.28 14.18 *0.0145 0.7913 0.7379-0.8448 0.0876 65 (10.9)
urgent procedures 488 0.8-56.2 30.6 (6.3) 32 (6.6) 1.05 6.44 *0.0921 0.7067 0.6246-0.7887 0.0606 32 (6.6)
emergency procedures 77 1.9-65.5 14.6 (19.0) 25 (32.5) 1.71 12.63 **0.0055 0.7708 0.6602-0.8814 0.1945 21 (27.3)
salvage procedures 28 6.2-71.8 8.8 (31.3) 12 (42.9 1.36 9.39 **0.0245 0.5626 0.3269-0.7986 0.2649 12 (42.86)
TOTAL 2287 0.5-71.8 103.2 (4.5) 123 (5.4) 1.19 23.70 0.0084 0.8177 0.7786-0.8569 0.0443 119 (5.2)
Exp: expected mortality.
Obs: observed mortality.
O/E: observed-expected mortality ratio.
HL: Hosmer-Lemeshow test.
ROC AUC: receiver operating characteristics, area under the curve.
CI: confidence interval.
BS: Brier score.
*three groups in HL-test
**five groups in HL-test
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Figure 4 Comparison of the logistic EuroSCORE’s and
EuroSCORE II’s ROC curves.
6 G. Koszta et al.
HLC 1581 1–10
Please cite this article in press as: Koszta G, et al. Performance of EuroSCORE II in Hungary: A Single-centre Validation Study.
Heart, Lung and Circulation (2014), http://dx.doi.org/10.1016/j.hlc.2014.04.005
240 calibrations were also unsatisfactory. However, the devia-
241 tions were smaller compared with the single non-coronary
242 procedures.
243 The Brier score was lowest in the isolated CABG group
244 0.0195 with the lowest frequency (2.1%) of the patients with
245 higher than 0.25. The BS increased with the complexity of the
246 intervention and reached a rather high level of 0.1225 among
247 those patients who underwent the most complex operations,
248 indicating that the risk prediction was ambiguous in 13.2% of
249 the patients in this group.
250 Analysis of the Procedural Urgency
251 Subgroups
252 The O:E ratio of the elective procedures was 1.1 with no
253 significant deviation between observed and expected mor-
254 tality (HL-test p=0.1396). Both the ROC analysis and the BS
255 revealed good discriminative power and accuracy in this
256 subgroup.
257 In the urgent operation group theO:E ratio of 1.045 showed
258 only a small difference and the result of the HL-test was not
259 significant (p=0.0921). The ROC AUC reached only the
260 acceptable level; however, the Brier scores were equal or
261 higher than 0.25 in only 6.6% of the patients, which is slightly
262 higher than this ratio in the whole cohort.
263 In the emergency and the salvage groups neither the cali-
264 bration nor the accuracy proved to be satisfactory with very
265 high ratios of ambiguous predictions. We can observe a
266 discrepancy between the result of ROC analysis and the Brier
267 score in the emergency group, where the ROC AUC was as
268 high as 0.7708, but the mean BS was 0.1945 with a ratio of
269 27.27% for BS0.25.
270Cross References Between the
271Subgroups
272Table 6 contains cross references among the subgroups. It can
273be seen that, in general, the O:E ratios increase with the
274degree of urgency. This Table also reveals the causes of
275the surprisingly high O:E ratio in the single non-coronary
276group by revealing that the ratios of the emergency and the
277salvage operations were disproportionally high compared
278with the other subgroups.
279Discussion
280The data collection for this validation study began after the
281completion of the EuroSCORE II project’s recruitment phase.
282Consequently, these results are probably free from the effect
283of the continuous performance decline described previously
284by Hickey et al [6].
We have not found major differences in the composition of
285the risk predictors compared with the reported data in the
286original EuroSCORE II paper [1]. The mean age of our cohort
287was less than two years older and the ratio of female partic-
288ipantswas slightly higher.No clinicallymeaningful difference
289was found in the ratio of elective and non-elective operations.
290In accordance with other validation studies we have
291proved that EuroSCORE II is more precise in the outcome
292prediction than its predecessor [2]. The new EuroSCORE
293effectively and reliably predicted the risk for the majority
294of the patients who underwent the most frequent coronary
295bypass procedures and proved to be satisfactory in general
296when the operation was performed electively. The O:E ratio
Table 6 Cross references among the subgroups.
Weight of intervention Urgency
elective urgent emergency salvage total
CABG
n 723 277 36 2 1038
O 4 8 10 2
E 13.1 9.9 5.9 0.5
single non-CABG
n 406 53 18 14 491
O 10 4 8 8
E 8.4 2.4 3.2 3.1
two procedures
n 445 102 17 12 576
O 24 10 7 4
E 18.5 10.3 4.2 5.2
three procedures
n 120 56 6 0 182
O 16 10 0 0
E 9.4 7.9 1.32 0
total 1694 488 77 28 2287
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297 of 0.75 indicated that EuroSCORE II tends to overestimate the
298 real risk in coronary patients. However, it did not reach the
299 level of statistical significance.
300 EuroSCORE II under-estimated the real risk in those
301 patients with higher than 0.6 EuroSCORE II p-values. The
302 broad and widening confidence interval on the smoothed
303 calibration curve in the higher risk categories is another sign
304 indicating the uncertainty of the prediction.
305 The second area of poor goodness-of-fit was that of the
306 emergency and the salvage procedures. The unsatisfactory
307 calibration in the single non-coronary group is probably
308 partially the consequence of the disproportionally higher
309 ratio of emergency and salvage operations in this group.
310 The other possible explanation is the older age of the patients
311 who underwent aortic valve replacement. Theywere approx-
312 imately five years older than the mean of the cohort.
313 The incidence of patients with a BS equal or higher, than
314 0.25was also calculated.We interpreted this ratio as amarker
315 of uncertainty of prediction. It was fairly low: 2.1% among
316 the coronary patients and 3.3% in the elective procedures.
317 However, our results showed that more than 10% of the
318 patients received uninformative or evenmisleading forecasts
319 regarding the probability of death within the postoperative
320 30 days when non-elective procedures were needed. This
321 ratio was more than one-quarter among the patients who
322 underwent emergency operations and only a little lower than
323 half in salvage operations. The ROC area reached lowest level
324 in the salvage operations. However, we must add here that
325 the low number of patients in this cohort prevents us from
326 drawing profound conclusions. These findings are in keep-
327 ing with the results of the recently published paper by Grant
328 et al [7] on the performance of the new EuroSCORE among
329 emergency patients. Besides the inadequate accuracy,
330 they have found an almost perfect O:E ratio in this group.
331 However, EuroSCORE II overestimated the probability of
332 mortality among the high-risk patients conversely compared
333 with our own results.
334 The question may thus be raised as to whether these
335 findings in the non-elective subgroups are due to the poor
336 calibration of EuroSCORE II or whether other local and
337 healthcare-related factors also have to be taken into account?
338 When searching for an answer to the first part of the ques-
339 tion, some practical aspects needed to be mentioned.
340 EuroSCORE II gave inaccurate predictionswhen emergency
341 operations were needed. This is understandable in situa-
342 tions where incomplete information collection may contrib-
343 ute to the more difficult prediction of the expectable
344 outcome. It is also likely that the acutely deteriorated phys-
345 iology results in more complex and multiple ways of the
346 interactions among the risk factors. Unfortunately, interac-
347 tions were not defined in EuroSCORE II. In addition to
348 older age, those determinants that may modify the effect
349 of other risk predictors most extensively probably account
350 for the different degrees of urgency. Careful evaluation of
351 the results provided by other studies may help exposing the
352 local factors that otherwise cannot be distinguished from the
353 inadequate calibration.
354Table 7 summarises the results of some recently published
355validation studies [8–15]. It is clearly noticeable that the
356calibration of EuroSCORE II is not perfect when all types
357of procedures are evaluated together. The results of the
358subgroup analyses are also discordant.
359In a large validation study [11] Chalmers et al found an
360acceptable goodness-of- fit in the isolated CABG group with
361an immediately not significant H-L p-value. In contrast to our
362results, the new EuroSCORE showed excellent performance
363in the isolated MVR group with a highly non-significant
364Hosmer-Lemeshow test and an almost perfect ROC AUC.
365It was even better than in the isolated AVR group.
366A multi-centre validation study published by Bareli et al
367[8] concluded that the new version of EuroSCORE is not
368satisfactorily calibrated. Although it did well in the low risk
369categories, it increasingly over-predicted the risk of death
370among patients with higher than 0.4 EuroSCORE II p-values,
371a result which is contrary to our own findings. Concernswere
372also raised about the inclusion of non-significant risk factors
373that failed to increase the performance. The lack of a clinically
374important high risk condition such as post-infarct septal
375rupture was questioned.
376Zhang et al [15] performed a validation study among
377patients who underwent valve surgery. EuroSCORE II’s
378goodness-of-fit was excellent in the single valve surgery
379group, while it significantly underestimated the risk in the
380multiple valve group.
381Another paper was published from China by Wang et al
382[14]. More than 11,000 other-than-coronary procedures were
383evaluated in multiple-centre setting. The EuroSCORE II non-
384significantly over-predicted the risk even in the combined
385operation groups.
Probably the largest validation study to date was that pub-
386lished by Grant et al [13]. The sample size was comparable to
387the original derivation dataset. Prospective data collection
388involved all cardiac surgical centres in the UK. This study
389found good accuracy, but poor overall goodness- of-fit. The
390subgroup analysis indicated inadequate calibration in the
391CABG group, where the new EuroSCORE II, similar to our
392results, overestimated the real likelihood of mortality. The
393calibration and the accuracy were excellent or satisfactory in
394the other surgical subgroups. Carnero-Alca´zar et al [10] found
395very similar EuroSCORE II performance compared to the
396present study.
In a dataset fromLiverpool [16], UK anO:E ratio of 1.38was
397published. Similarly to our result their analysis clearly
398revealed the EuroSCORE II’s tendency to under-predict the
399risk especially in the higher risk categories. The new Euro-
400SCORE did not improve the risk prediction comparedwith its
401old version as reported in collaborative study from two Euro-
402pean centres [17].
We are well aware of the limitations of our study, of which
403probably the greatest is the single-centre design. The sample
404size of our dataset is not small in general; however, it did not
405provide enough cases to perform an analysis of the specific
406operation types such as procedures on different heart valves
407and the ascending aorta. The relatively low number of
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408 emergencypatients inour cohortmade it necessary to examine
409 the results of many other centres.
410 Conclusions
411 The new EuroSCORE indicated variably lower-than-real risk
412 in the case of valve and combined surgeries and among high
413 risk patients.
414 A perfectly calibrated preoperative risk stratification
415 model is probably a theoretical illusion, because it also lacks
416 the information of several not-included, ‘‘minor’’ factors [18]
417 as well as the effect of intraoperative and postoperative
418 events, which may additively modify the outcome. These
419 individual or healthcare related factors may be systematic or
420 sporadic. The former – if they have a negative impact on the
421 patients’ outcome – should be revealed and corrected during
422 continuous quality control.
423 The effect of the intraoperative and early postoperative
424 factors may be reflected most practically in the course of the
425 postoperative parameters [19] and biomarkers such as car-
426 diac troponines.
427 The new EuroSCORE can be considered a timely and
428 necessary update of the former model with room left to
429improve on its performance. More frequent recalibration is
430essential to keep track of the changing practice [6]. Defining
431interactions between risk predictors in the logistic model
432may result in better performance [20], primarily in emer-
433gency procedures.
We think that the results of different cardiac surgical centres
434are comparable reliablyon thebasisof auniversalEuroSCRE II
435risk model. However, an institutionally or regionally re-cali-
436brated version of the original model may be necessary when
437used to facilitate the clinical decision making in those centres,
438where the characteristics of health care or the patients are
439different from the Western-European ones.
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Table 7 Review of the main results of EuroSCORE II validation studies.
author year country, setting cohort O:E ratio HL, p ROC AUC
Chalmers [10] 2006-2010 UK, single-centre all procedures, n=5576 1.1 <0.001 0.79
CABG, n=2913 1.12 0.052 0.79
AVR, n=814 1.1 0.07 0.69
MVR, n=340 0.71 0.6 0.87
AVR+CABG, n=517 1.0 0.38 0.74
aortic, n=351 1.21 0.43 0.81
misc.,n=642 1.84 0.99 0.7
Barili [7] 2006-2011 Italy, multicentre all procedures, n=12325 0.79 <0.05 0.82
Biancari [8] 2006-2011 Finland, single-centre CABG, n=1027 1.2 not reported 0.852
Di Dedda [11] 2010-2011 Italy, single-centre all procedures, n=1090 1.21 0.22 0.81
Carnero-Alca´zar [9] 2005-2010 Spain, single-centre all procedures, n=3798 1.27 <0.001 0.851
CABG, n=1231 0.94 0.001 0.9
valvular, n=1727 1.39 <0.001 0.827
combined, n=301 1.37 0.334 0.769
aortic, n=416 1.24 0.058 0.85
other, n=123 1.82 0.334 0.876
Zhang [14] 2006-2011 China, single-centre heart valve surgery, n=3479 1.28 <0.0001 0.685
single valve, n=1106 1.03 0.103 0.792
multiple valve, n=2373 1.23 <0.0001 0.605
Grant [12] 2010-2011 UK, Ireland, multicentre all procedures, n=23740 0.92 0.003 0.808
isolated CABG, n=12470 0.71 0.001 0.796
single non-CABG, 4984 1.06 0.398 0.781
two procedures, n=4766 1.04 0.108 0.731
three procedures, n=1520 0.96 0.044 0.733
isolated AVR, n=3116 0.81 0.319 0.772
AVR+CABG, n=2401 0.92 0.424 0.770
Performance of EuroSCORE II in Hungary 9
HLC 1581 1–10
Please cite this article in press as: Koszta G, et al. Performance of EuroSCORE II in Hungary: A Single-centre Validation Study.
Heart, Lung and Circulation (2014), http://dx.doi.org/10.1016/j.hlc.2014.04.005
448 References
449 [1] Nashef SA, Roques F, Sharples L, Nilsson J, Smith C, Goldstone AR,
450 et al. EuroSCORE II. Eur J Cardiothorac Surg 2012;41:734–44.
451 [2] Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon
452 R. European system for cardiac operative risk evaluation (EuroSCORE).
453 Eur J Cardiothorac Surg 1999;16:9–13.
454 [3] Farsang C, Naditch-Brule L, Perlini S, Zidek W, Kjeldsen SE. Inter-
455 regional comparisons of the prevalence of cardiometabolic risk factors in
456 patients with hypertension in Europe: the GOOD survey. J Hum Hyper-
457 tens 2009;23:316–24.
458 [4] Steyerberg E, Vickers A, Cook N, Gerds T, Gonen M, Obuchowski N,
459 et al. Assessing the performance of prediction models: a framework for
460 traditional and novel measures. Epidemiology 2010;21:128–38.
461 [5] Gutierrez R, Linhart J, Pitblado J. From the help desk: Local polynomial
462 regression and Stata plugins. Stata Journal 2003;3:412–9.
463 [6] Hickey G, Grant S, MurphyG, BhabraM, PaganoD, McAllister K, et al.
464 Dynamic trends in cardiac surgery: why the logistic EuroSCORE is no
465 longer suitable for contemporary cardiac surgery and implications for
466 future risk models. Eur J Cardiothorac Surg 2013;43:1146–52.
467 [7] Grant S, Hickey G, Dimarakis I, Cooper G, Jenkins D, Uppal R, et al.
468 Performance of the EuroSCORE models in emergency cardiac surgery.
469 Circ Cardiovasc Qual Outcomes 2013;6:178–85.
470 [8] Barili F, Pacini D, CapoA, Rasovic O, Grossi C, Alamanni F, et al. Does
471 EuroSCORE II perform better than its original versions? A multicentre
472 validation study. Eur Heart J 2013;34:22–9.
473 [9] Biancari F, Vasques F, Mikkola R, Martin M, Lahtinen J, Heikkinen J.
474 Validation of EuroSCORE II in patients undergoing coronary artery
475 bypass surgery. Ann Thorac Surg 2012;93:1930–5.
476 [10] Carnero-Alcazar M, Silva Guisasola J, Reguillo Lacruz F, Maroto
477 Castellanos L, Cobiella Carnicer J, Villagran Medinilla E, et al. Valida-
478 tion of EuroSCORE II on a single-centre 3800 patient cohort. Interact
479 Cardiovasc Thorac Surg 2013;16:293–300.
480[11] Chalmers J, Pullan M, Fabri B, McShane J, ShawM, Mediratta N, et al.
481Validation of EuroSCORE II in a modern cohort of patients undergoing
482cardiac surgery. Eur J Cardiothorac Surg 2013;43:688–94.
483[12] Di Dedda U, Pelissero G, Agnelli B, De Vincentiis C, Castelvecchio S,
484Ranucci M. Accuracy, calibration and clinical performance of the new
485EuroSCORE II risk stratification system. Eur J Cardiothorac Surg 2013;
48643:27–32.
487[13] Grant S, Hickey G, Dimarakis I, Trivedi U, Bryan A, Treasure T, et al.
488How does EuroSCORE II perform in UK cardiac surgery; an analysis of
48923,740 patients from the Society for Cardiothoracic Surgery in Great
490Britain and Ireland National Database. Heart 2012;98:1568–72.
491[14] Wang L, HanQQ, Qiao F, WangC, Zhang X, Han L, et al. Performance
492of EuroSCORE II in patients who have undergone heart valve surgery: a
493multicentre study in a Chinese population. Eur J Cardiothorac Surg 2013.
494[15] Zhang G, Wang C, Wang L, Lu F, Li B, Han L, et al. Validation of
495EuroSCORE II in Chinese Patients Undergoing Heart Valve Surgery.
496Heart Lung Circ 2013;22:606–11.
497[16] KirmaniB, MazharK, FabriB, PullanD. Comparisonof theEuroSCOREII
498and Society of Thoracic Surgeons 2008 risk tools. Eur J Cardiothorac Surg
4992013.
500[17] Howell N, Head S, Freemantle N, van der Meulen T, Senanayake E,
501Menon A, et al. The new EuroSCORE II does not improve prediction of
502mortality in high-risk patients undergoing cardiac surgery: a collabora-
503tive analysis of two European centres. Eur J Cardiothorac Surg 2013.
504[18] Head S, Osnabrugge R, Howell NJ, Freemantle N, Bridgewater B,
505Pagano D, et al. A systematic review of risk prediction in adult cardiac
506surgery: considerations for future model development. Eur J Cardio-
507thorac Surg 2013;43:e121–9.
508[19] Tamayo E, Fierro I, Bustamante J, Heredia-Rodriguez M, Monjas P,
509Maroto L, et al. Development of the Post Cardiac Surgery (POCAS)
510prognostic score. Crit Care 2013;17:R209.
511[20] HosmerD, LemeshowS. AppliedLogistic Regression, 2nd ed.,NewYork:
512Wiley-Blackwell; 2000.
10 G. Koszta et al.
HLC 1581 1–10
Please cite this article in press as: Koszta G, et al. Performance of EuroSCORE II in Hungary: A Single-centre Validation Study.
Heart, Lung and Circulation (2014), http://dx.doi.org/10.1016/j.hlc.2014.04.005
